Worth Venture Partners, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$3.45 - $4.69 $1.19 Million - $1.62 Million
-344,702 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$2.97 - $3.83 $225,779 - $291,156
76,020 Added 28.29%
344,702 $1.15 Million
Q3 2020

Nov 16, 2020
BUY
$2.97 - $5.08 $165,524 - $283,118
55,732 Added 26.17%
268,682 $798,000
Q2 2020

Aug 14, 2020
SELL
$3.48 - $5.05 $75,429 - $109,458
-21,675 Reduced 9.24%
212,950 $983,000
Q1 2020

May 15, 2020
BUY
$2.61 - $5.21 $612,371 - $1.22 Million
234,625 New
234,625 $903,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.14B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email